November 22, 2010 11:08 ET

New Report Predicts Growth for Drug Delivery Technologies

ROCKVILLE, MD--(Marketwire - November 22, 2010) - has announced the addition of MarketsandMarkets's new report "Top 10 Drug Delivery Technologies (2010 - 2015)" to their collection of Drug Delivery market reports. For more information, visit

The increasing demand for effective delivery of novel biopharmaceuticals is driving the growth of the global top 10 drug delivery technologies market. Further, patent expirations of drugs is also boosting market growth. The global top 10 drug delivery technologies market is expected to grow from $43.8 billion in 2009 to $81.5 billion in 2015, at an estimated CAGR of 11% from 2010 to 2015. The time release technologies market commands the largest share of the overall top 10 drug delivery technologies market owing to immense popularity of once-daily formulations.

Unconventional modes of drug delivery such as pulmonary, nasal and transdermal are gaining a lot of popularity especially in chronic disease conditions such as diabetes, hypertension, CNS and cancer. Nanotechnology advances have led to the development of innovative drug delivery systems.

This research report categorizes the global market top 10 drug delivery technologies on the basis of their growth, therapeutic areas, patents registered, and industry focus. The report analyzes geography; forecasting revenues and trends in each of the following submarkets:

  • Time release technologies
  • Targeted delivery
  • Aerosol technology
  • Encapsulation technology
  • Topical formulations
  • Injectables
  • Trandermal patch
  • Implant technology
  • Liposomal drug delivery
  • PEGlyation technology

Each section will provide market data, market drivers, trends and opportunities, top-selling products, key players, and competitive outlook. This report will also provide market tables for covering the sub-segments and micro-markets. In addition, the report also provides more than 20 company profiles covering all the sub-segments.

For more information, visit

Contact Information